The Cancer Cell (CC) Formula is an experimental treatment that is currently being researched on cancer, infectious and other diseases.
This technology targets cells which do not follow the Krebs metabolic cycle by delivering a lethal dose of minerals (zinc and copper) to those cells. Because cancer cells follow an anaerobic, non-Krebs metabolism, it is predicted to target cancer cells precisely.
Between 5 and 10 percent of all patients contract at least one hospital-acquired infection.
Also known as a healthcare-associated infection or nosocomial infection—during their stay in an acute care hospital. According to estimates from the National Nosocomial Infections Surveillance (NNIS) system, in 2002, approximately 1.7 million cases of HAIs and 99,000 associated deaths occurred in U.S. hospitals, leading to extra costs of up to $6.5 billion each year.
To breakthrough, the medical industry is devoting time and money to cellular biology and developing treatments that effectively shut down genes tied to life-threatening diseases and genetic disorders like MRSA.